1-cyclohexyl-3-[4-[2-[(4-oxo-3H-phthalazin-1-yl)amino]ethyl]phenyl]urea

ID: ALA4761521

PubChem CID: 162514666

Max Phase: Preclinical

Molecular Formula: C23H27N5O2

Molecular Weight: 405.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)NC1CCCCC1

Standard InChI:  InChI=1S/C23H27N5O2/c29-22-20-9-5-4-8-19(20)21(27-28-22)24-15-14-16-10-12-18(13-11-16)26-23(30)25-17-6-2-1-3-7-17/h4-5,8-13,17H,1-3,6-7,14-15H2,(H,24,27)(H,28,29)(H2,25,26,30)

Standard InChI Key:  UJSBBPJVNSFMNR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   19.0343  -13.8469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7437  -13.4424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7437  -12.6211    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0343  -12.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0343  -14.6682    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0343  -11.3829    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7461  -10.9743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3290  -13.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3316  -12.6229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6243  -12.2127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9139  -12.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9154  -13.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6232  -13.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4528  -11.3847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1615  -10.9779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8641  -11.3904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5723  -10.9843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5748  -10.1662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8632   -9.7560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1578  -10.1645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2830   -9.7585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9902  -10.1679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6984   -9.7602    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9893  -10.9851    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.4056  -10.1696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3999  -10.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1031  -11.3969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8137  -10.9927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8166  -10.1745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1089   -9.7607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9  4  1  0
  8  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  1  5  2  0
  4  6  1  0
  6  7  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 23 25  1  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4761521

    ---

Associated Targets(Human)

AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.50Molecular Weight (Monoisotopic): 405.2165AlogP: 4.03#Rotatable Bonds: 6
Polar Surface Area: 98.91Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.87CX Basic pKa: 3.69CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.50Np Likeness Score: -1.41

References

1. Zhang XJ,Xu Y,Mou HX,Wang S,Hao SY,Chen SW.  (2020)  The synthesis and anti-tumour properties of novel 4-substituted phthalazinones as Aurora B kinase inhibitors.,  30  (23.0): [PMID:32941989] [10.1016/j.bmcl.2020.127556]

Source